RAC1 and ovarian cancer: The treatment inhibited the actin-bundling into stress fibers as well as ovarian cancer cell migration by reducing GTP-bound Cdc42 and Rac1, further indicating a therapeutic role of G2 in ovarian cancer [140,150].